Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

PWRM, MFI, PSTR, CVCY- Stock Reports from Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, today announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

Parkinson’s disease generally has an effect on people more than 50 years old. Beginning symptoms of PD usually are subtle and also take place slowly. When it comes to some people the condition advances more rapidly compared with others. The fact that the ailment progresses, the shaking, or tremor, which usually is affecting the majority of PD individuals may turn to restrict every day actions. Other signs and symptoms can sometimes include melancholy as well as other emotive adjustments; trouble in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. Presently there are still no blood or laboratory tests which have been proven to support in figuring out sporadic PD. Because of this the medical diagnosis is dependant on track record and a neurological examination. The actual illness can be hard to identify precisely. Physicians may possibly sometimes demand brain scans or laboratory tests so that they can eliminate other diseases.

Soon after cancer of the skin, cancers of the breast is a very common cancer recognized in females. However breast cancer rates have decreased in recent times, even if physicians are not certain why. Nevertheless, for numerous ladies, breast cancer could be the condition they fear most.

Alzheimer’s doesn’t have any immediate cure, but remedies for indicators can be found and investigate carries on. Even though current Alzheimer treatment options cannot cease Alzheimer’s disease from progressing, they’re able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer’s disease as well as all their caregivers. Today, there exists a international exertion under approach to finding better ways to take care of the condition, postponement its onset, and prevent it from escalating.

MicroFinancial Inc. (Nasdaq:MFI) announced that the Board of Directors of MicroFinancial Incorporated declared a cash dividend of $0.05 per common share payable on February 15, 2011, to holders of record of MFI common stock at the close of business on February 1, 2011. This dividend represents the same amount per common share as the last dividend paid by MFI, in November 2010.
MicroFinancial Incorporated, through its subsidiaries, operates as a specialized commercial finance company that provides microticket equipment leasing and other financing services in the United States. The company provides financing alternatives, and leases and rents commercial equipment to start-up and established businesses for use in their daily operations.

PostRock Energy Corporation (Nasdaq:PSTR) announced that it has completed the second phase of its previously announced sale of certain assets in West Virginia to Magnum Hunter Resources Corporation (NYSE:MHR - News) ("MHR"). The consideration for the first two phases of the sale totaled $39.7 million. The purchase agreement also provides for MHR to acquire a third, smaller package of assets upon satisfaction of certain events and conditions. There can be no assurance that the sale of this third package will occur.
PostRock Energy Corporation, an integrated independent energy company, engages in the acquisition, exploration, development, production, and transportation of oil and natural gas in the United States. It operates in two segments, Oil and Gas Production, and Natural Gas Pipelines.

Central Valley Community Bancorp (Nasdaq:CVCY) the Board of Directors of Central Valley Community Bancorp (NASDAQ:CVCY), is pleased to report that the investment banking firm Sandler O'Neill + Partners, L.P. has listed the Company's stock in their 2011 Top Investment Ideas report, released January 6, 2011. The Company was previously included in their 2010 Top Investment Ideas report.
Central Valley Community Bancorp operates as the bank holding company for the Central Valley Community Bank that provides commercial banking and financial services to individuals, businesses, and professional communities in California.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.